Last reviewed · How we verify
NCT00233467
Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade
trial in PTSD. Withdrawn.
30 September 2005
Quick facts
| Lead sponsor | Tuscaloosa Research & Education Advancement Corporation |
|---|---|
| Status | Withdrawn |
| Study type | OBSERVATIONAL |
| Start date | 1 September 2005 |
| Primary completion | 30 September 2005 |
| Estimated completion | 30 September 2005 |
| Sites | 1 location across United States |
Conditions studied
- PTSD — all drugs for PTSD →
- Posttraumatic Stress Disorder — all drugs for Posttraumatic Stress Disorder →
Sponsor
Tuscaloosa Research & Education Advancement Corporation
Who can join
19 and older, any sex, with PTSD or Posttraumatic Stress Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main purpose is to show the percentage of patients taking antipsychotics with PTSD by looking at approximately ten year's worth of data from 1994 through 2004. We will also determine the type and dose of antipsychotics the patients received, and to determine how many of those patients had psychotic versus nonpsychotic symptoms. We will be obtaining this data from the VISN 7 Corporate Data Warehouse. We hypothesize that there has been an overall increase in antipsychotic use in patient's with PTSD over the last 10 years.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT00233467
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for PTSD
Currently open trials in the same condition.
- NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting
- NCT07010757 — Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial · NA · recruiting
- NCT07372586 — Behavioral Health Collaborative Care Model in an ICU Recovery Clinic · NA · recruiting
- NCT07390786 — Behavioral Health Collaborative Care Model in Post-ICU Clinic Family Pilot · NA · recruiting
- NCT07469098 — Group vs Individual MDMA-Assisted Therapy for PTSD After the October 7, 2023 Events · Phase 2 · recruiting
Other Tuscaloosa Research & Education Advancement Corporation trials
Trials by the same sponsor.
- NCT05690243 — Minds Navigating the Diagnosis of Mild Cognitive Impairment · NA · unknown
- NCT00659230 — Nepicastat for Posttraumatic Stress Disorder (PTSD) in OIF/OEF Veterans · Phase 2 · completed
- NCT01394081 — Alabama Veterans Rural Health Initiative · NA · completed
- NCT00315900 — Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia · Phase 3 · terminated
- NCT00451542 — Divalproex vs. Lamotrigine for Bipolar Disorder · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00233467 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tuscaloosa Research & Education Advancement Corporation
- Last refreshed: 14 September 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00233467.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing